Drug Shortage Report for BOOSTRIX-POLIO
Report ID | 19888 |
Drug Identification Number | 02312557 |
Brand name | BOOSTRIX-POLIO |
Common or Proper name | Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | INACTIVATED POLIOVIRUS TYPE I INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE III TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED PERTUSSIS TOXOID ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTACTIN ADSORBED |
Strength(s) | 40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 10's |
ATC code | J07CA |
ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-11-08 |
Estimated end date | 2017-12-07 |
Actual end date | 2017-12-06 |
Shortage status | Resolved |
Updated date | 2017-12-07 |
Company comments | Supply released November 10, 2017 with limited quantity. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.